• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 drug practices risk antimicrobial resistance evolution.

作者信息

Afshinnekoo Ebrahim, Bhattacharya Chandrima, Burguete-García Ana, Castro-Nallar Eduardo, Deng Youping, Desnues Christelle, Dias-Neto Emmanuel, Elhaik Eran, Iraola Gregorio, Jang Soojin, Łabaj Paweł P, Mason Christopher E, Nagarajan Niranjan, Poulsen Michael, Prithiviraj Bharath, Siam Rania, Shi Tieliu, Suzuki Haruo, Werner Johannes, Zambrano Maria Mercedes, Bhattacharyya Malay

机构信息

Department of Physiology and Biophysics, Weill Cornell Medicine, New York, USA.

The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, USA.

出版信息

Lancet Microbe. 2021 Apr;2(4):e135-e136. doi: 10.1016/S2666-5247(21)00039-2. Epub 2021 Feb 24.

DOI:10.1016/S2666-5247(21)00039-2
PMID:33655229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7906697/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7156/7906697/2c312ab21aab/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7156/7906697/2c312ab21aab/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7156/7906697/2c312ab21aab/gr1.jpg

相似文献

1
COVID-19 drug practices risk antimicrobial resistance evolution.新冠病毒疾病药物治疗方法存在引发抗菌药物耐药性演变的风险。
Lancet Microbe. 2021 Apr;2(4):e135-e136. doi: 10.1016/S2666-5247(21)00039-2. Epub 2021 Feb 24.
2
Treatment of COVID-19: implications for antimicrobial resistance in Africa.2019冠状病毒病的治疗：对非洲抗菌药物耐药性的影响
Pan Afr Med J. 2020 Jul 20;35(Suppl 2):119. doi: 10.11604/pamj.supp.2020.35.23713. eCollection 2020.
3
In Pursuit of COVID-19 Treatment Strategies: Are We Triggering Antimicrobial Resistance?寻求新冠治疗策略：我们是否正在引发抗菌素耐药性？
Disaster Med Public Health Prep. 2022 Aug;16(4):1285-1286. doi: 10.1017/dmp.2020.492. Epub 2020 Dec 22.
4
Azithromycin Use in COVID-19 Patients: Implications on the Antimicrobial Resistance.阿奇霉素在新冠肺炎患者中的应用：对抗菌药物耐药性的影响
Curr Top Med Chem. 2021;21(8):677-683. doi: 10.2174/156802662108210319145317.
5
Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides?新型冠状病毒肺炎疫情下的抗菌药物耐药性：抗感染抗体和抗菌肽是否有机会？
Front Immunol. 2022 Jun 2;13:921483. doi: 10.3389/fimmu.2022.921483. eCollection 2022.
6
[The silent pandemic - antimicrobial resistance].[无声的大流行——抗菌药物耐药性]
Laeknabladid. 2022 Mar;108(3):119. doi: 10.17992/lbl.2022.03.678.
7
Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak.抗微生物药物耐药性：在新冠疫情背后潜伏的无形威胁。
Indian J Pharmacol. 2021 May-Jun;53(3):187-191. doi: 10.4103/ijp.ijp_430_21.
8
Antimicrobial resistance and COVID-19: Intersections and implications.抗微生物药物耐药性与 COVID-19：交叉与影响。
Elife. 2021 Feb 16;10:e64139. doi: 10.7554/eLife.64139.
9
Severe adverse drug reaction in SARS-CoV-2 infection: AGEP induced by ceftriaxone and confirmed by patch test.新型冠状病毒感染中的严重药物不良反应：头孢曲松诱发并经斑贴试验确诊的急性泛发性脓疱性皮病
Contact Dermatitis. 2021 Sep;85(3):366-368. doi: 10.1111/cod.13857. Epub 2021 Apr 23.
10
COVID-19: Clouds Over the Antimicrobial Resistance Landscape.COVID-19：抗生素耐药性领域的阴云。
Arch Med Res. 2021 Jan;52(1):123-126. doi: 10.1016/j.arcmed.2020.10.010. Epub 2020 Oct 10.

引用本文的文献

1
Incidence, clinical and genomic trends of hospital- and Non-hospital-onset KPC-producing Klebsiella pneumoniae infections before and during the COVID-19 era: a ten-year interrupted time series study.COVID-19 时代之前及期间医院内和非医院内产 KPC 肺炎克雷伯菌感染的发病率、临床及基因组趋势：一项十年中断时间序列研究
Antimicrob Resist Infect Control. 2025 Aug 7;14(1):97. doi: 10.1186/s13756-025-01614-6.
2
Impact of the COVID-19 Pandemic on Hospital Antimicrobial Purchasing in Canada (2018-2021): An Exploratory Analysis.2018 - 2021年新冠疫情对加拿大医院抗菌药物采购的影响：一项探索性分析
J Assoc Med Microbiol Infect Dis Can. 2025 May 29;10(2):146-159. doi: 10.3138/jammi-2024-0017. eCollection 2025 Jun.
3

本文引用的文献

1
Dexamethasone and remdesivir: finding method in the COVID-19 madness.地塞米松和瑞德西韦：在新冠疫情的疯狂中寻找方法。
Lancet Microbe. 2020 Dec;1(8):e309-e310. doi: 10.1016/S2666-5247(20)30173-7. Epub 2020 Oct 23.
2
Co-infections: testing macrolides for added benefit in patients with COVID-19.合并感染：测试大环内酯类药物对COVID-19患者的附加益处。
Lancet Microbe. 2020 Dec;1(8):e313. doi: 10.1016/S2666-5247(20)30170-1. Epub 2020 Nov 2.
3
Co-infections: potentially lethal and unexplored in COVID-19.合并感染：在新冠病毒病中可能致命且未被探索。
Mitigating Antibiotic Resistance: The Utilization of CRISPR Technology in Detection.
减轻抗生素耐药性：CRISPR技术在检测中的应用
Biosensors (Basel). 2024 Dec 20;14(12):633. doi: 10.3390/bios14120633.
4
Bacteriophage entrapment strategies for the treatment of chronic wound infections: a comprehensive review.噬菌体包埋策略治疗慢性伤口感染：全面综述。
Arch Microbiol. 2024 Oct 23;206(11):443. doi: 10.1007/s00203-024-04168-0.
5
Microbiome Geographic Population Structure (mGPS) Detects Fine-Scale Geography.微生物组地理种群结构（mGPS）可检测到细微的地理尺度。
Genome Biol Evol. 2024 Nov 1;16(11). doi: 10.1093/gbe/evae209.
6
Removal of tetracycline from the aquatic environment using activated carbon: A comparative study of adsorption performance based on the activator agents.使用活性炭从水生环境中去除四环素：基于活化剂的吸附性能比较研究。
Heliyon. 2024 Jul 14;10(14):e34637. doi: 10.1016/j.heliyon.2024.e34637. eCollection 2024 Jul 30.
7
Recent Advances in the Development of Antibiotics-Coated Gold Nanoparticles to Combat Antimicrobial Resistance.用于对抗抗菌耐药性的抗生素包被金纳米颗粒的研发新进展
Antibiotics (Basel). 2024 Jan 26;13(2):124. doi: 10.3390/antibiotics13020124.
8
Fluorescence sensor based on optimized quantum yield manganese-carbon polymer dots and smartphone-integrated sensing platform for tetracycline detection.基于优化量子产率的锰-碳聚合物点的荧光传感器和智能手机集成传感平台用于四环素检测。
Mikrochim Acta. 2024 Feb 16;191(3):141. doi: 10.1007/s00604-024-06225-3.
9
Hospital Antibiotic Consumption before and during the COVID-19 Pandemic in Hungary.匈牙利新冠疫情之前及期间的医院抗生素使用情况
Antibiotics (Basel). 2024 Jan 20;13(1):102. doi: 10.3390/antibiotics13010102.
10
Antibiotic resistance and the COVID-19 pandemic: A dual crisis with complex challenges in LMICs.抗生素耐药性与新冠疫情：低收入和中等收入国家面临的双重危机及复杂挑战
Health Sci Rep. 2023 Sep 13;6(9):e1566. doi: 10.1002/hsr2.1566. eCollection 2023 Sep.
Lancet Microbe. 2020 May;1(1):e11. doi: 10.1016/S2666-5247(20)30009-4. Epub 2020 Apr 24.
4
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.追踪 SARS-CoV-2 刺突蛋白的变化：D614G 增加 COVID-19 病毒感染力的证据。
Cell. 2020 Aug 20;182(4):812-827.e19. doi: 10.1016/j.cell.2020.06.043. Epub 2020 Jul 3.
5
The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for Pharmacovigilance.COVID-19“信息疫情”对药物利用行为的影响：对药物警戒的启示。
Drug Saf. 2020 Aug;43(8):699-709. doi: 10.1007/s40264-020-00965-w.
6
Cartography of opportunistic pathogens and antibiotic resistance genes in a tertiary hospital environment.机遇性病原体和抗生素耐药基因在三级医院环境中的图谱。
Nat Med. 2020 Jun;26(6):941-951. doi: 10.1038/s41591-020-0894-4. Epub 2020 Jun 8.
7
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
8
Nosocomial outbreak of COVID-19 pneumonia in Wuhan, China.中国武汉发生的 COVID-19 肺炎医院感染暴发。
Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.00544-2020. Print 2020 Jun.
9
Effectiveness of convalescent plasma therapy in severe COVID-19 patients.恢复期血浆疗法治疗重症 COVID-19 患者的疗效。
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.
10
Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance.药物渗透不完全会导致空间单药治疗和多药耐药性的快速演变。
Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):E2874-83. doi: 10.1073/pnas.1424184112. Epub 2015 May 18.